[PDF][PDF] Mutant p53 prolongs NF-κB activation and promotes chronic inflammation and inflammation-associated colorectal cancer

T Cooks, IS Pateras, O Tarcic, H Solomon, AJ Schetter… - Cancer cell, 2013 - cell.com
T Cooks, IS Pateras, O Tarcic, H Solomon, AJ Schetter, S Wilder, G Lozano, E Pikarsky
Cancer cell, 2013cell.com
The tumor suppressor p53 is frequently mutated in human cancer. Common mutant p53
(mutp53) isoforms can actively promote cancer through gain-of-function (GOF) mechanisms.
We report that mutp53 prolongs TNF-α-induced NF-κB activation in cultured cells and
intestinal organoid cultures. Remarkably, when exposed to dextran sulfate sodium, mice
harboring a germline p53 mutation develop severe chronic inflammation and persistent
tissue damage, and are highly prone to inflammation-associated colon cancer. This mutp53 …
Summary
The tumor suppressor p53 is frequently mutated in human cancer. Common mutant p53 (mutp53) isoforms can actively promote cancer through gain-of-function (GOF) mechanisms. We report that mutp53 prolongs TNF-α-induced NF-κB activation in cultured cells and intestinal organoid cultures. Remarkably, when exposed to dextran sulfate sodium, mice harboring a germline p53 mutation develop severe chronic inflammation and persistent tissue damage, and are highly prone to inflammation-associated colon cancer. This mutp53 GOF is manifested by rapid onset of flat dysplastic lesions that progress to invasive carcinoma with mutp53 accumulation and augmented NF-κB activation, faithfully recapitulating features frequently observed in human colitis-associated colorectal cancer (CAC). These findings might explain the early appearance of p53 mutations in human CAC.
cell.com